Dr. C. Thomas Caskey This is Me
View Title...
Brown Foundation Institute of Molecular Medicine for the Prevention of Human Diseases
Please Note:
This profile was automatically generated using 390 references found on the Internet. This information has not been verified. Learn more...
This profile was automatically generated using 390 references found on the Internet. This information has not been verified. Learn more...
View all 390 references Web References
-
1. Etubics Corporation
www.etubics.com/tc.html - [Cached]Published on: 8/16/2008 Last Visited: 8/16/2008
C. Thomas CaskeyEtubics Corporation
...
C. Thomas Caskey, M.D., F.A.C.P., is Director and Chief Executive Officer of the Brown Foundation Institute of Molecular Medicine for the Prevention of Human Diseases (IMM) and Executive Vice-President of Molecular Medicine and Genetics at the University of Texas Health Science Center at Houston.He has served on the Company's Board of Directors since 2007.
Dr. Caskey was Chief Executive Officer and President of Cogene Biogene Ventures and Cogene Ventures, venture capital funds designed to support early-stage biotechnology and life sciences companies using genome technology for drug discovery.He served as Senior Vice-President, Human Genetics and Vaccines Discovery at Merck Research Laboratories, West Point, PA and as President of the Merck Genome Research Institute.He was Chairman of the board of Lexicon as the company transformed itself from a mouse discovery company to a Nasdaq listed pharmaceutical corporation.
Dr. Caskey is a graduate of the University of South Carolina (Phi Beta Kappa) and Duke Medical School (Alpha Omega Alpha).He has received numerous academic and industry-related honors.His genetic research documented the Universality of the Genetic Code, discovered the mechanism of peptide chain termination, identified the genetic basis of 10 major heritable diseases, opened the understanding of triplet repeat diseases (Fragile X, myotonic dystrophy and others), developed the STR method of personal identification (now used worldwide) for forensic studies, and developed a viral vector vaccine for HIV.He is Past President of the American Society of Human Genetics and the Human Genome Organization.He served as Chair of the Advisory Panel on Forensic Uses of DNA Tests, U.S. Congress Office of Technology Assessment, 1989-1990.He served as President of the Academy of Medicine, Engineering and Science of Texas from 2004-2006.Dr. Caskey currently serves on the Governor's Committee of 17, which has oversight of the Texas 200 million Emerging Technology Fund.He is a member of the National Academy of Sciences and the Institute of Medicine. -
2. Board of Directors
www.envivopharma.com/template/ - [Cached]Published on: 6/23/2008 Last Visited: 6/23/2008
C. Thomas Caskey, M.D. (Brown Foundation Institute of Molecular Medicine - Univ. of Texas)
C. Thomas Caskey, M.D., F.A.C.P., is Director and Chief Executive Officer-Elect and Chief Operating Officer of the Brown Foundation Institute of Molecular Medicine for the Prevention of Human Diseases (IMM), at the University of Texas Health Science Center at Houston.Dr. Caskey was founding director of Houston-based Cogene Biotech Ventures and Cogene Ventures, venture capital funds supporting early-stage biotechnology and life sciences companies.The fund, founded in March 2000, invested in companies that utilize genome technology to enable drug discovery in high growth therapeutic specialties such as cancer, neurology and the metabolic diseases of obesity and diabetes.Dr. Caskey has received numerous academic and industry-related honors.He is a member of the National Academy of Sciences and the Institute of Medicine.He has served as president of American Society of Human Genetics, the Human Genome Organization and The Academy of Medicine, Engineering and Science of Texas (TAMEST).He previously served as senior vice president for human genetics and vaccines discovery at Merck Research Laboratories from 1994 to 2000 and as president of the Merck Genome Research Institute from 1998 to 2000.He received the Distinguished Texas Geneticist Award from the Texas Genetics Society in 1998 and serves on Texas Governor Rick Perry's Council on Science and Biotechnology, which makes funding recommendations for the $200 million Texas Emerging Technology Fund.Dr. Caskey earned his medical degree from Duke University School of Medicine and his undergraduate degree from the University of South Carolina.He is Board certified in Internal Medicine, Clinical Genetics, Metabolic Diseases and Molecular Diagnostics. -
3. TAMEST :: The Academy of Medicine, Engineering and Science of Texas
www.tamest.org/about/bios.php - [Cached]Published on: 8/27/2008 Last Visited: 8/27/2008
Dr. Michael S. Brown | Dr. J. Tinsley Oden | Dr. Daniel W. Foster | Dr. David E. Daniel | Dr. Irma Gigli | Dr. Stephen A. Holditch | Mr. Kenneth E. Arnold | Dr. Paul F. Barbara | Dr. Arthur L. Beaudet | Dr. William R. Brinkley | Dr. C. Thomas Caskey | Dr. Francisco G. Cigarroa | Dr. Kenneth I. Shine | Dr. Max D. Summers | Dr. Harry L. Swinney | Dr. Richard A. Tapia | Dr. James J. Truchard | Dr. Ellen S. Vitetta | Dr. Huda Y. Zoghbi
...
Dr. C. Thomas CaskeyDirector, Institute of Molecular MedicineThe University of Texas Health Science Center at Houston
C. Thomas Caskey is a graduate of the University of South Carolina, and Duke University Medical School.He has received numerous academic and industry-related honors.His genetic research documented the Universality of the Genetic Code, discovered the mechanism of peptide chain termination, identified the genetic basis of 10 major heritable diseases, opened the understanding of triplet repeat diseases (Fragile X, myotonic dystrophy and others) to genetic �anticipation�, developed the STR method of personal identification (now used worldwide) for forensic studies, and developed a viral vector vaccine for HIV (now in Phase III at Merck).
Dr. Caskey is currently the Director of the Institute of Molecular Medicine at The University of Texas Health Science Center at Houston . He has served as Chief Executive Officer and President of Cogene Biotech Ventures, Ltd., Senior Vice President, Human Genetics and Vaccines Discovery at Merck Research Laboratories, West Point , Pa. and President of the Merck Genome Research Institute.He serves as an Adjunct Professor, Department of Molecular & Human Genetics at Baylor College of Medicine, Houston, Texas.He is past President of the American Society of Human Genetics, Human Genome Organization, and TAMEST.He is a member of the Institute of Medicine and the National Academy of Sciences.
Dr. Caskey is on the Board of Directors of Lexicon Genetics, Odyssey Thera, Envivo, Argolyn, and MAS.

